Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: A multicenter study

Journal of Women's Health

Volumn 21, Issue 8, 2012, Pages 813-820

  Perkins, Rebecca B ^a   Brogly, Susan B ^b   Adams, William G ^c   Freund, Karen M ^d  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; MENINGOCOCCUS VACCINE; WART VIRUS VACCINE;

ADOLESCENCE; ADOLESCENT; ADULT; ARTICLE; CANCER INCIDENCE; CHILD; CORRELATION ANALYSIS; ELECTRONIC MEDICAL RECORD; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE FACILITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MINORITY GROUP; MULTICENTER STUDY (TOPIC); PAPILLOMAVIRUS INFECTION; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SCHOOL CHILD; UTERINE CERVIX CANCER; VACCINATION; VACCINATION RATE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BOSTON; CHILD; COHORT STUDIES; COMMUNITY HEALTH CENTERS; FAMILY PRACTICE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMMUNIZATION PROGRAMS; LOGISTIC MODELS; MEDICAID; MULTIVARIATE ANALYSIS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PEDIATRICS; POVERTY; PRIMARY HEALTH CARE; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 84864695501     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2011.3364     Document Type: Article

References (24)

1. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-819.
2. Kahn JA, Lan D, Kahn RS. Sociodemographic factors asso-ciated with high-risk human papillomavirus infection. Ob-stet Gynecol 2007;110:87-95.
3. Goel MS, Wee CC, McCarthy EP, Davis RB, Ngo-Metzger Q, Phillips RS. Racial and ethnic disparities in cancer screening: The importance of foreign birth as a barrier to care. J Gen Intern Med 2003;18:1028-1035.
4. Centers for Disease Control and Prevention. Available at www.cdc.gov/cancer/cervical/statistics/. Accessed Janu-ary 22, 2011
5. Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quad-rivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007;356:1928-1943.
6. Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL. HPV type-distribution in women with and without cervical neo-plastic diseases. Vaccine 2006;24 (Suppl 3):S26-34.
7. Flannery B, Schrag S, Bennett NM, et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA 2004;291:2197-2203.
8. Villa LL, Costa RL, Petta CA, et al. Prophylactic quadri-valent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II effi-cacy trial. Lancet Oncol 2005;6:271-278.
9. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among adolescents aged 13-17 years\United States, 2010. MMWR 2011;60:1117-1123.
10. Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epi-demiol 2010;171:357-367.
11. Widdice LE, Bernstein DI, Leonard AC, Marsolo KA, Kahn JA. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics 2011;127:77-84.
12. Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clin Proc 2009;84:864-870.
13. Daley MF, Crane LA, Markowitz LE, et al. Human papillo-mavirus vaccination practices: A survey of U.S. physicians 18 months after licensure. Pediatrics 2010;126:425-433.
14. Kahn JA, Cooper HP, Vadaparampil ST, et al. Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: A statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev 2009;18:2325-2332.
15. McCave EL. Influential factors in HPV vaccination uptake among providers in four states. J Community Health 2010;35: 645-652.
16. Battaglia TA, Santana MC, Bak S, et al. Predictors of timely follow-up after abnormal cancer screening among women seeking care at urban community health centers. Cancer 2010;116:913-921.
17. Advisory Committee on Immunization Practices. Quad-rivalent human papillomavirus vaccine: Recommendations of the Advisory Committe on Immunization Practices. MMWR 2007;56(No RR-2).
18. Daley EM, Vamos CA, Buhi ER, et al. Influences on human papillomavirus vaccination status among female college students. J Womens Health 2010;19:1885-1891.
19. Guerry SL, De Rosa CJ, Markowitz LE, et al. Human pap-illomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine 2011;29:2235-2241.
20. Groom H, Kennedy A, Evans V, Fasano N. Qualitative analysis of immunization programs with most improved childhood vaccination coverage from 2001 to 2004. J Public Health Manag Pract 2010;16:E1-8.
21. Fiks AG, Hunter KF, Localio AR, et al. Impact of electronic health record-based alerts on influenza vaccination for chil-dren with asthma. Pediatrics 2009;124:159-169.
22. Gorin SS, Ashford AR, Lantigua R, et al. Effectiveness of academic detailing on breast cancer screening among pri mary care physicians in an underserved community. J Am Board Fam Med 2006;19:110-121.
23. LeBaron CW, Mercer JT, Massoudi MS, et al. Changes in clinic vaccination coverage after institution of measurement and feedback in 4 states and 2 cities. Arch Pediatr Adolesc Med 1999;153:879-886.
24. Dini EF, Chaney M, Moolenaar RL, LeBaron CW. Informa-tion as intervention: How Georgia used vaccination cover-age data to double public sector vaccination coverage in seven years. J Public Health Manag Pract 1996;2:45-49.